Global cardiometabolic risk profile in @entity1 with XXXX : results from the Turkish arm of the pan-European GOOD survey.

@entity1 @entity101 @entity6 @entity233 @entity28 @entity2299 @entity209
OBJECTIVES: We evaluated the results of the Turkish arm of the GOOD survey which investigated the cardiometabolic risk profile and the control of blood pressure (BP) of adult @entity101 outpatients in 12 countries across Europe. STUDY DESIGN: A total of 218 @entity101 @entity1 (139 females, 79 males; mean age 57.2  10.9 years) from @entity233 were included in this pan-European survey. Blood pressure control (defined as BP <140/90 mmHg for nondiabetics and <130/80 mmHg for @entity6 ) and cardiometabolic risk factors such as @entity6 , @entity209 , @entity28 , sedentary lifestyle, and @entity2299 were evaluated in accordance with the 2003 ESH/ESC guidelines on management of @entity101 . RESULTS: Control of BP was achieved in only 21.6% of the @entity1 diagnosed with @entity101 for a mean duration of 7.7  5.4 years. The mean systolic and diastolic BPs were 144  21 mmHg and 88  14 mmHg, respectively. The most frequent concomitant disease was @entity6 (66 @entity1 , 30.3%). @entity1 with @entity6 had a higher prevalence of @entity209 compared to nondiabetics (78.8% vs. 48%, p<0.01). The absence of BP control was more pronounced among @entity6 than in nondiabetics for systolic (77.3% vs. 63.8%) and diastolic (84.9% vs. 57.2%) pressures. Nearly half of the @entity101 @entity1 had @entity2299 , but only 35.8% of them were treated with lipid lowering drugs. CONCLUSION: Despite appropriate treatment, poor BP control in Turkish @entity101 @entity1 was associated with @entity209 , @entity6 , and undertreatment of @entity2299 . Therefore, more effective measures must be taken in the management of cardiovascular risk factors to improve BP control.
